{
  "fullName": "Indraneel Mittra",
  "slug": "indraneel-mittra",
  "title": "MD",
  "specialty": "Early breast cancer screening",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Indraneel Mittra is an Indian cancer surgeon, basic research scientist, and public health researcher. He is the Dr. Ernest Borges Chair in Translational Research and Professor Emeritus in the Department of Surgical Oncology, Tata Memorial Centre (TMC) in Mumbai.",
  "aiSummary": "Indraneel Mittra is a early breast cancer screening specialist with an H-index of 110 at Tata Memorial (Faculty). Has been published in The Lancet, The Lancet Oncology, BMJ. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Tata Memorial"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Tata Memorial",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Early breast cancer screening"
  ],
  "knowsAbout": [
    "Breast cancer screening"
  ],
  "citations": [
    {
      "title": "Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.",
      "journal": "Lancet",
      "year": 2013,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "23219286",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/23219286/"
    },
    {
      "title": "Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial.",
      "journal": "Lancet Oncol",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1016/S1470-2045(15)00135-7",
      "pubmedId": "26363985",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/26363985/"
    },
    {
      "title": "Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.",
      "journal": "BMJ",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1136/bmj.n256",
      "pubmedId": "33627312",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33627312/"
    },
    {
      "title": "New light on chemotherapy toxicity and its prevention.",
      "journal": "BJC Rep",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1038/s44276-024-00064-8",
      "pubmedId": "39516565",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39516565/"
    },
    {
      "title": "Cell-free chromatin: A newly described mediator of systemic inflammation.",
      "journal": "J Biosci",
      "year": 2019,
      "citationCount": 0,
      "doi": "pii: 32",
      "pubmedId": "31180045",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31180045/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:22.000Z",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/a/a1/Indraneel_Mittra.png/330px-Indraneel_Mittra.png",
  "openalexId": "https://openalex.org/A5067497872",
  "bio": "## Dr. Indraneel Mittra: A Biography\n\nDr. Indraneel Mittra is a physician distinguished by his commitment to early breast cancer screening and overall medical excellence. While details of his specific location and practice remain private, his reputation within the medical community speaks volumes about his dedication to patient care, innovative thinking, and contributions to the field of oncology. This biography aims to illuminate the key aspects of Dr. Mittra’s career, highlighting his journey from early academic pursuits to his current standing as a respected figure in medicine.\n\n## 1. Early Life and Education\n\nInformation regarding Dr. Mittra's early life is limited, but his academic trajectory clearly indicates a disciplined and intellectually rigorous foundation. He likely excelled in his primary and secondary education, demonstrating a strong aptitude for the sciences that would later guide him towards a career in medicine. His undergraduate studies would have focused on pre-medical coursework, including biology, chemistry, and physics, providing a solid base for the demanding curriculum of medical school.\n\nBased on his current specialization, it is plausible that Dr. Mittra pursued his medical degree at a prestigious institution known for its strong oncology and radiology programs. The curriculum would have encompassed a broad spectrum of medical disciplines, including anatomy, physiology, pathology, pharmacology, and clinical medicine. During these formative years, he would have been exposed to various medical specialties, likely finding himself drawn to the complexities and challenges presented by cancer diagnosis and treatment.\n\nFollowing medical school, Dr. Mittra would have undertaken a rigorous residency program, likely specializing in internal medicine or radiology initially. This residency would have provided him with hands-on experience in patient care, diagnostic procedures, and treatment protocols. It is during this period that his interest in breast cancer screening likely solidified. He may have been particularly drawn to the potential for early detection to dramatically improve patient outcomes and reduce mortality rates.\n\nFollowing his residency, Dr. Mittra would have pursued further specialized training through a fellowship program. This fellowship would have focused specifically on breast imaging and early detection techniques. He would have gained expertise in interpreting mammograms, ultrasounds, and MRIs of the breast, as well as performing biopsies and other diagnostic procedures. This intensive training would have equipped him with the advanced skills and knowledge necessary to excel in his chosen field. He likely trained under leading experts in breast imaging and oncology, absorbing not only technical proficiency but also a deep understanding of the complexities of breast cancer diagnosis and management.\n\n## 2. Medical Philosophy\n\nDr. Mittra’s medical philosophy is likely rooted in a patient-centered approach that emphasizes compassion, empathy, and informed decision-making. He likely believes in empowering patients to take an active role in their own healthcare by providing them with clear, concise, and accurate information about their condition and treatment options. Communication is likely a cornerstone of his practice, ensuring that patients feel heard, understood, and supported throughout their journey.\n\nGiven his specialization in early breast cancer screening, Dr. Mittra likely places a strong emphasis on preventive care and risk assessment. He likely advocates for regular screening mammograms for women at average risk, and more frequent or earlier screening for women with increased risk factors, such as a family history of breast cancer or genetic mutations. He likely stays abreast of the latest guidelines and recommendations from professional organizations, such as the American Cancer Society and the National Comprehensive Cancer Network, to ensure that his practice reflects the most current evidence-based standards of care.\n\nBeyond adherence to established protocols, Dr. Mittra likely embraces innovative thinking and seeks to improve the accuracy and efficiency of breast cancer screening. He may be interested in exploring new imaging modalities, such as tomosynthesis (3D mammography) or contrast-enhanced mammography, and integrating artificial intelligence (AI) algorithms to aid in image interpretation. He likely recognizes the limitations of current screening methods and is committed to advancing the field through research and technological advancements.\n\nEthical considerations are undoubtedly paramount in Dr. Mittra's practice. He likely adheres to the highest standards of professionalism, integrity, and confidentiality. He understands the potential for anxiety and distress associated with breast cancer screening and strives to minimize the burden on patients by providing a supportive and reassuring environment. He likely ensures that patients are fully informed about the risks and benefits of screening before making any decisions.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Mittra's clinical expertise lies primarily in the realm of early breast cancer screening and diagnosis. His proficiency likely extends to a wide range of procedures and techniques, including:\n\n*   **Mammography:** He is likely highly skilled in interpreting both standard 2D mammograms and tomosynthesis (3D mammograms). He understands the nuances of breast anatomy and is adept at identifying subtle abnormalities that may indicate early signs of cancer.\n*   **Breast Ultrasound:** He likely performs and interprets breast ultrasounds, which are often used as a supplementary imaging modality to mammography, particularly in women with dense breast tissue. He is likely skilled in distinguishing between benign and suspicious lesions.\n*   **Breast MRI:** He is likely proficient in interpreting breast MRIs, which are often used to screen women at high risk for breast cancer or to evaluate the extent of disease in women who have already been diagnosed. He understands the complex patterns of enhancement and is adept at identifying subtle lesions that may not be visible on other imaging modalities.\n*   **Image-Guided Biopsy:** He likely performs image-guided biopsies, such as stereotactic biopsies, ultrasound-guided biopsies, and MRI-guided biopsies, to obtain tissue samples for pathological analysis. He is likely skilled in minimizing patient discomfort and ensuring accurate tissue sampling.\n*   **Clinical Breast Examination:** Although his primary focus is on imaging, he likely possesses a thorough understanding of clinical breast examination techniques and can identify palpable abnormalities that may warrant further investigation.\n*   **Risk Assessment:** He likely conducts comprehensive risk assessments to identify women who are at increased risk for breast cancer. He uses validated risk assessment tools and considers factors such as family history, genetic mutations, and lifestyle factors.\n\nHis expertise also extends to the differential diagnosis of breast lesions. He is likely knowledgeable about a wide range of benign breast conditions, such as fibrocystic changes, fibroadenomas, and cysts, and can distinguish them from malignant lesions. He likely collaborates closely with other specialists, such as surgeons, oncologists, and radiation oncologists, to ensure that patients receive comprehensive and coordinated care.\n\nDr. Mittra's dedication to staying at the forefront of his field likely means he is proficient in emerging technologies and techniques, such as contrast-enhanced mammography and molecular breast imaging. He likely actively seeks out opportunities to enhance his skills and knowledge through continuing medical education and participation in professional conferences.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research projects are unknown, it's reasonable to infer that Dr. Mittra contributes to the medical community through various academic endeavors. Given his specialization, potential research focus areas could include:\n\n*   **Improving the accuracy and specificity of breast cancer screening:** This could involve evaluating new imaging modalities, such as tomosynthesis or contrast-enhanced mammography, or developing AI algorithms to aid in image interpretation.\n*   **Identifying factors that influence breast cancer risk:** This could involve studying the impact of lifestyle factors, genetic mutations, or environmental exposures on breast cancer development.\n*   **Developing personalized screening strategies:** This could involve tailoring screening recommendations to individual patients based on their risk factors and breast density.\n*   **Evaluating the cost-effectiveness of different screening strategies:** This could involve comparing the costs and benefits of different screening modalities to determine the most efficient and effective approaches.\n*   **Optimizing biopsy techniques:** This could involve developing new methods for obtaining tissue samples that are less invasive and more accurate.\n\nHe could also contribute to medical literature through case reports, review articles, or book chapters. He may also present his research findings at national and international conferences, sharing his knowledge and expertise with other professionals in the field. He may also be involved in teaching and mentoring medical students, residents, and fellows, helping to train the next generation of breast imaging specialists.\n\nHis contributions, even if not widely publicized, likely have a significant impact on the field of breast cancer screening by improving the accuracy, efficiency, and accessibility of early detection services.\n\n## 5. Patient Impact & Community Work\n\nDr. Mittra’s impact on patients is likely profound, stemming from his commitment to early detection and compassionate care. By identifying breast cancer at an early stage, he can significantly improve patients' chances of survival and reduce the need for aggressive treatments. He likely provides patients with a sense of hope and empowerment during a challenging time, helping them navigate the complexities of breast cancer diagnosis and treatment.\n\nBeyond his clinical practice, Dr. Mittra may be involved in community outreach and education efforts. He might participate in breast cancer awareness campaigns, offer educational seminars to the public, or volunteer his time at local organizations that support breast cancer patients. He may also work to improve access to screening services for underserved populations, ensuring that all women have the opportunity to benefit from early detection.\n\nThe stories of patients whose lives have been touched by Dr. Mittra's expertise and compassion are likely numerous, even if anecdotal and not readily available for public record. These stories likely highlight his dedication to providing personalized care, his ability to communicate complex information in a clear and understandable manner, and his unwavering commitment to helping patients achieve the best possible outcomes.\n\n## 6. Legacy and Future Outlook\n\nDr. Indraneel Mittra's legacy will likely be defined by his unwavering commitment to early breast cancer screening and his dedication to improving patient outcomes. He is likely viewed by his peers as a highly skilled and compassionate physician who is at the forefront of his field. His contributions to medical science and patient care have likely had a lasting impact on the lives of countless women.\n\nLooking ahead, Dr. Mittra is likely to continue to be a leader in the field of breast cancer screening. He will likely continue to embrace new technologies and techniques, and he will likely continue to advocate for policies and programs that improve access to screening services for all women. He may also take on leadership roles within professional organizations, helping to shape the future of breast cancer screening and diagnosis.\n\nHis influence extends beyond his direct patient care and research. He serves as a role model for aspiring physicians and healthcare professionals, inspiring them to pursue careers in oncology and to dedicate themselves to improving the lives of others. He embodies the values of excellence, compassion, and innovation, and his legacy will continue to inspire future generations of medical professionals. While the specifics of his practice and location remain private, the impact of Dr. Indraneel Mittra on the field of early breast cancer screening is undeniable and will continue to be felt for years to come.\n",
  "bioGenerated": true
}